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Background: Crystallography and mutagenesis 
support that Asp309 is required for substrate 
binding and catalysis. 
Results: Substrate binding in aromatase is pH-
dependent. Such a dependency is missing in 
D309N mutant. 
Conclusions: The apparent pKa for Asp309 is 8.2 
and the residue is protonated at physiological pH. 
Significance: The assigned pKa supports the role 
of Asp309 in proton delivery for aromatization 
reaction.  
 
ABSTRACT  
Aromatase (CYP19A1), the enzyme that 
converts androgens to estrogens, is of 
significant mechanistic and therapeutic 
interest.  Crystal structures and computational 
studies of this enzyme shed light on the critical 
role of D309 in substrate binding and catalysis. 
These studies predicted an elevated pKa for 
D309 and proposed that protonation of this 
residue was required for function. In this study, 
UV-vis absorption, circular dichroism, 
resonance Raman spectroscopy, and enzyme 
kinetics were used to study the impact of pH on 
aromatase structure and androstenedione 
binding. Spectroscopic studies demonstrate that 
androstenedione binding is pH-dependent, 
while in contrast, the D309N mutant retains its 
ability to bind to androstenedione across the 
entire pH range studied. Neither pH nor 
mutation perturbed the secondary structure or 
heme environment. The origin of the observed 
pH dependence was further narrowed to the 
protonation equilibria of D309 with a parallel 
set of spectroscopic studies using exemestane 
and anastrozole. Since exemestane interacts 
with D309 based on its co-crystal structure with 
the enzyme, its binding is pH-dependent. 
Aromatase binding to anastrozole is pH-
independent, consistent with the hypothesis that 
this ligand exploits a distinct set of interactions 
in the active site. In summary, we assign the 
apparent pKa of 8.2 observed for 
androstenedione binding to the side chain of 
D309. To our knowledge, this work represents 
the first experimental assignment of a pKa 
value to a residue in a cytochrome P450. This 
value is in agreement with theoretical 
calculations (7.7-8.1) despite the computational 
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methods reliance on the conformational 
snapshots provided by crystal structures.  
 
 
Human aromatase (CYP19A1) is the cytochrome 
P450 that catalyses the terminal step of estrogen 
biosyntheses, converting androstenedione, 
testosterone and 16α-hydroxytestosterone to 
estrone, 17β-estradiol and 17β,16α-estriol, 
respectively (1-3). This enzyme has drawn 
considerable interest for its ability to construct an 
aromatic ring and for its success as a breast cancer 
therapeutic target (4, 5). The reaction occurs in 
three distributive steps, each requiring one 
equivalent of molecular oxygen and NADPH (6). 
The first two steps are accepted to be 
hydroxylations of the steroid C19 methyl group, 
while the final step relies on a debated mechanism 
that deformylates the C19 aldehyde and 
aromatizes the steroid A-ring (Scheme 1A) (7). 
While the ferric peroxo species has been generally 
accepted to mediate the third catalytic step, recent 
studies by different groups strongly support the 
involvement of Compound I in the third lyase step 
(8, 9). Despite decades of investigation, additional 
mechanistic studies are warranted to understand 
the mechanisms of this complex, 
pharmacologically-relevant enzyme.  
Recently, crystal structures of CYP19A1 
have suggested that a protonated aspartic acid 
residue in the “acid-alcohol” pair (D309-T310) is 
critical for substrate binding, orientation and 
catalysis (10) (Figure 1).   Theoretical calculations 
based on one crystal structure (11) and site-
directed mutagenesis studies (12) supported the 
structural data. Furthermore, the crystal structures 
in complex with androstenedione revealed a close 
contact (2.7 Å) between the 3-keto oxygen atom of 
androstenedione and the δ-O atom of D309 (10, 
12). Similar distances between these atoms in the 
crystal structures with exemestane and other 
steroidal inhibitors have likewise been observed 
(13). An explanation for these close contacts is 
that D309 participates in a hydrogen bond to the 3-
keto oxygen atom (Figure 1). To permit this 
hydrogen-bonding configuration, the D309 side 
chain must be protonated and its pKa elevated 
relative to that measured for the free amino acid in 
aqueous solution. To the extent that it contributes 
to the acid-alcohol pair present in the active sites 
of many P450 enzymes, precise tuning of this 
residue’s pKa near physiological pH could 
optimize the reversible protonation required to 
drive the canonical P450 catalytic cycle. 
Computational prediction using an approach based 
on the Poisson Boltzmann equation and the crystal 
structure of human placental aromatase also 
estimated a pKa of 7.7 for D309 (11). Furthermore, 
subsequent hybrid quantum mechanics/molecular 
mechanics studies of the third catalytic step 
revealed a mechanism in which the D309 proton is 
cyclically relayed between the side chain and the 
substrate to circumvent accumulation of charge 
and stabilize intermediates in the 
deformylation/aromatization reaction (11). While 
inferences from crystallography suggest 
protonation of D309 and theory highlights the 
potential value of this proton for catalysis, 
additional experimental evidence is required to 
support an elevated pKa for D309 in aromatase.  
 In a previous work, using a N-terminally 
truncated form of human aromatase expressed in 
E. coli (rArom-WT) and sharing the same 
structural and functional features of the full-length 
wild-type enzyme, we found that the mutation of 
D309 to a non-titratable asparagine residue 
abolishes aromatase catalytic activity (12). In the 
present work, we describe the pH dependence of 
aromatase ligand binding. Exploiting the reliable 
spin state transition that occurs upon binding of 
androstenedione in the active site, we measured 
the enzyme’s ability to retain androstenedione 
using UV-vis and resonance Raman (rR) 
spectroscopy. Taken together with spectroscopic 
experiments using the D309N mutant, the steroidal 
inhibitor exemestane and the azole inhibitor 
anastrozole, the results lead us to assign an 
elevated pKa to D309 in aromatase, supporting a 
critical role for this residue. Additionally, in order 
to investigate potential physiological implications, 
possible variations in the catalytic parameters were 
also investigated in the pH regime where the 
enzyme is catalytically active in the physiological 
environment of the cell that ranges from 6.5 to 7.4. 
 
EXPERIMENTAL PROCEDURES 
 
Computational pKa predictions  
pKa values of the ionizable residues in the 
available crystal structures of rArom, including 
D309, were calculated using the empirical pKa 
predictor PROPKA3 (14).  
4 
 
Expression and purification of rArom and the 
D309N mutant  
Recombinant aromatase (rArom-WT) was 
expressed and purified as described previously 
(15). The enzyme was purified in the absence of 
ligand, with 10 µM of androstenedione, 10 µM of 
exemestane or 1 µM anastrozole. The D309N 
mutant was purified in the presence of 500 µM of 
androstenedione to improve yields of this protein. 
The P450 content of purified aromatase samples 
were measured using reduced CO-difference 
spectra. The CO binding assay was performed at 
30 °C by monitoring the absorbance at 450 nm 
after complete reduction of rArom with 12.5 mM 
sodium dithionite and bubbling with CO. Enzyme 
concentrations were determined using the 
differences in absorbance at 450 and 490 nm 
(A450-490) in [Fe2+CO]-[Fe2+] difference spectra 
and an extinction coefficient at 450 nm for the 
Fe2+CO complex of 91,000 M-1 cm-1 (16). All UV-
vis absorption measurements were made with an 
Agilent 8453E UV-vis spectrophotometer.  
 
UV-vis absorption and ligand titrations  
Androstenedione binding in the active site of 
aromatase results in a reliable shift of the heme 
iron from a low (S=1/2) to high (S=5/2) spin 
electronic configuration. Typical of P450 
enzymes, this spin shift results from displacement 
of the distal water ligand by the substrate (17). In 
aromatase, this is evidenced by a shift in the Soret 
band from 418 nm (low spin) to 394 nm (high 
spin) as androstenedione is titrated into the 
enzyme (15). The pH dependence of the shift in 
the Soret band was evaluated using two 
approaches. First, rArom (1 µM) purified in the 
absence of added ligands was incubated with 10 
µM androstenedione for five minutes at 25 °C in 
0.1 M potassium phosphate buffer for pH 6.5 – 8.0 
and 0.1 M Tris buffer for pH 8.5 and 9.0.  Second, 
the experiment was performed using rArom co-
purified with 10 µM androstenedione and 
incubated for 5 minutes at 25 °C at different pH. 
All buffers used in the UV-vis-absorption 
titrations also contained 20% glycerol, 0.1% 
Tween 20, and 1 mM β-mercaptoethanol. The 
percentage of enzyme in the high-spin state (HS) 
was calculated as follows. Since there is no 
detectable high-spin enzyme at pH 10 and no 
detectable low-spin enzyme at pH 6.5, the spectral 
difference in the absorbance at 394 nm and at 418 
nm between these two spectra 
(A394pH=6.5 − A394pH=10 )− (A418pH=6.5 − A418pH=10 )  are 
defined as (ΔA394-ΔA418)max and set to 100% HS. 
The percent of high-spin enzyme (%HS) at the 
remaining pH values were calculated as 
100(ΔA394-ΔA418)/ (ΔA394-ΔA418)max. This 
transformation was necessary to compare different 
set of experiments with slightly varying protein 
concentrations. pKa values were determined by 
fitting the percentages of high-spin enzyme and 
pH values to the equation: 
 
%HS = yMIN + (yMAX-yMIN) / 1+10(pH-pKa)            (1) 
 
using SigmaPlot 10.0. yMAX and yMIN are the 
asymptotic values of the sigmoidal fit (18).  
Dissociation constants for 
androstenedione were determined by monitoring 
the shift in the Soret band from 418 to 394 nm as 
the concentration was titrated from 0.1 µM to 10 
µM androstenedione into 0.5-1 µM rArom in 0.1 
M potassium phosphate buffer for pH 6.5 – 8.0 
and 0.1 M Tris buffer for pH 8.5 and 9.0. After 
each ligand addition, equilibrium conditions were 
reached after 3 minutes at 25°C and the spectra 
recorded. The dissociation constants Kd were 
calculated using the equation:  
 
ΔA394-418 = ΔA max 394-418 • [S]free / (Kd + [S]free) 
      
(2) 
where [S]free  is [S]total–[E·S] and [E·S] = ΔA394-418 
[E]total / ΔAmax394-418. 
 
Since the addition of the steroidal inhibitor 
exemestane causes the same low-to-high spin 
transition as the substrate, the pH-dependence for 
exemestane binding was studied in the same 
experimental conditions as for androstenedione 
and the Kd values calculated on the basis of 
equation 2.  
The pH-dependence for anastrozole 
binding was likewise tested over the 
aforementioned pH range by monitoring the red-
shift of the Soret band from 418 to 422 nm that 
results from replacement of the distal water ligand 
with the nitrogen heterocycle of the inhibitor (19). 
Titrations with increasing amounts of anastrozole 
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(0.05-1 µM) were also performed to determine the 
pH dependence of the Kd values for this ligand. 0.1 
M potassium phosphate buffer was used for pH 
6.5 – 8.0 and 0.1 M Tris buffer for pH 8.5 and 9.0. 
Also in this case, after each ligand addition, the 
sample was equilibrated for 3 minutes at 25°C 
before recording the spectrum. The dissociation 
constants Kd were calculated using the equation: 
 
ΔA422-418 = ΔAmax 422-418 • [I]free / (Kd + [I]free) 
      
                (3) 
where [I]free is [I]total–[E·I]   and [E·I] = ΔA422-418 
[I]total / ΔAmax422-418. 
 
Circular dichroism spectroscopy  
Far-UV (200-250 nm) CD spectra were collected 
using 1 µM of rArom-WT in a 0.1 cm path length 
cell. All CD spectra were recorded at room 
temperature on a Jasco-815 instrument (Jasco 
Instruments, Inc., Japan).  
 
Resonance Raman spectroscopy  
rR spectra were obtained following excitation 
using the 406.7 nm line of a Coherent Innova 
302C krypton ion laser. Laser powers at the 
sample were 35 mW.  Spectra were collected 
using a f/9.7 single grating monochromator (Acton 
SP2750, Princeton Instruments) at a 100 micron 
slit width using 1800 grooves/mm gratings, and 
imaged using a 1340 x 400 pixel back-illuminated 
CCD camera with UV optimized coatings (PyLoN 
400BR eXcelon, Princeton Instruments). Reported 
spectra are the mean of three, 20-minute scans and 
are unsmoothed. Reference calibrations were 
performed with respect to a Hg vapor lamp. The 
nonlinear fluorescence background of rR spectra 
were removed using asymmetric least squares (20) 
in MATLAB. The concentrations of rArom and 
D309N were 10-15 µM in 0.1 M potassium 
phosphate (pH 6.5-8.0) buffer containing 5% 
glycerol and either containing 10 µM 
androstenedione or 1 µM anastrozole.  0.1 M 
Bicine buffer was used for measurements at pH 
8.5 and 9.0.  To determine the relative Raman 
cross sections of the ν3 band arising from the high- 
and low-spin states of rArom, 0.2 M potassium 
sulfate was added as an internal standard to 
samples that were essentially high- or low spin 
rArom. The ν3 bands of the heme and the 981 cm-1 
band of the sulfate ion to were fit to Gaussian line 
shapes using nonlinear least squares. Their 
corresponding intensities were determined by 
numerical integration of the peak areas. Following 
normalization of the high- and low-spin ν3 band 
intensities to the sulfate intensities, the high- to 
low- spin intensity ratio (IHS/ILS) was determined 
to be 0.68. This value was used to compute the 
relative populations of the high- and low spin 
populations of rArom and D309N, which in this 
work are expressed as the percent of the enzyme in 
the high spin state. Bands contributing to the 
propionates, vinyl, and 1620-1650 cm-1 regions 
were deconvoluted using two- and three-Gaussian 
fits in MATLAB.  
 
Substrate turnover. Aromatase activity assay was 
carried out by the water release method (21). The 
protein (30 nM) was incubated with 30 nM of 
human cytochrome P450-reductase (Invitrogen) 
and the substrate 1-β-3H-androstenedione (Perkin-
Elmer) for 5 minutes at room temperature. The 
reaction was then initiated by the addition of 1 
mM NADPH and incubated for 10 minutes at 37 
°C. The reaction was terminated with the addition 
of trichloroacetic acid (30% v/v). The precipitated 
material was pelleted by centrifugation and the 
resulting supernatant was subject to solid-phase 
extraction using a Strata X solid-phase extraction 
column (Phenomenex) to remove the unreacted 1-
β-3H-androstenedione. The eluted aqueous phase 
containing 3H2O was counted with a Tri-Carb 
2100TR liquid scintillation analyzer. (Packard 
Bioscience)  
 
RESULTS 
Empirical pKa predictions 
The PROPKA3 method was used to estimate the 
pKa value of D309 in the available crystal 
structures of aromatase. PROPKA is an empirical 
method that has been parameterized with a set of 
85 experimentally-determined pKa values of 
aspartate and glutamate residues in proteins. 
Utilizing a test set of 201 Asp and Glu pKa values, 
the rmsd error of this approach was shown to be 
0.79 pH units. The previously estimated pKa for 
D309 in the crystal structure of full-length human 
placental aromatase bound to androstenedione was 
predicted to be 7.7 (11). Additional crystal 
structures of the placental and recombinant 
aromatase with androstenedione and steroidal 
inhibitors have since become available and they all 
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suggest the presence of a hydrogen bond between 
the 3-keto oxygen atom androstenedione and the 
δ-O atom of D309. Accordingly, PROPKA3 also 
predicts pKa values for D309 in the range 7.7-7.9 
in these structures (Table 1). The PROPKA 
analysis predicted a slightly higher pKa of 8.1 for 
the truncated form of aromatase used in this work. 
This variation is not of concern because these 
calculations are performed using crystal structures, 
which represent snapshots of the protein 
conformation and do not reflect the solution 
conformational heterogeneity of the enzyme. 
Furthermore, minor differences in the 
crystallization conditions, packing effects, and 
ligand-induced perturbations of the protein 
conformation induce minor differences in the 
electrostatic environment of the ionizable residues, 
thereby resulting in slightly different pKa 
predictions. Nonetheless, the PROPKA3 method 
consistently predicts a substantially elevated pKa 
for D309 across available crystal structures and 
the fluctuations in these predictions are well 
within the standard deviation reported for the 
computational method.   
 
UV-visible titrations with androstenedione 
The pH-dependence of the spin shift that is reliant 
on the presence of androstenedione in the active 
site was investigated by UV-vis absorption 
spectroscopy using enzyme purified with and 
without saturating amounts of androstenedione. 
The UV-vis spectra of rArom-WT at different pH 
values are illustrated in Figure 2A. This pH range 
was selected because the sodium dithionite 
reduced form of the enzyme effectively binds CO 
and has a Soret band at 450 nm in the UV-vis 
absorption spectrum consistent with properly 
folded, functional enzyme. At pH lower than 5.5 
and higher than 10, the Soret band is found at 420-
422 nm for rArom-WT in the absence of ligand 
and the protein is not able to bind CO and show 
the typical peak at 450 nm, even in the presence of 
androstenedione. In general, at pH values greater 
than 7.0, there is a partial high-to-low spin shift of 
the Soret band from 394 to 418 nm, reflecting the 
displacement of androstenedione. When the pH is 
changed in the reverse direction, from 10 to 6.5, 
the opposite effect is observed with the Soret band 
shifting from 418 to 394 nm. An isosbestic point at 
407 nm is observed in both titrations. Incubating 
rArom-WT purified in the absence of ligand with 
saturating amounts of androstenedione, it was not 
possible to obtain a complete low-to-high spin 
transition at pH higher than 7.0. Control 
experiments using potassium phosphate buffers set 
at different concentrations to maintain consistent 
the ionic strengths at different pH (for example 
125 mM KPi pH 7.0 and 100 mM KPi pH 7.4) and 
using different buffers for the same pH values (for 
example 100 mM Tris and 100 mM bicine for pH 
8.5) were performed in order to exclude possible 
spin transition effects due to ionic strength and/or 
buffer composition. The pH-dependence of the 
high- and low-spin content evident in the UV-vis 
spectra were analyzed as described in the 
“Experimental procedures” section and the results, 
expressed as the percentage of high-spin enzyme, 
are illustrated in Figure 2C. In each case, the data 
are fitted using non-linear least squares to reveal 
an apparent pKa value for the spin transition. 
Using rArom-WT purified with and without 
androstenedione, the apparent pKa values are 8.2 ± 
0.3 and 8.1 ± 0.2, respectively. A global fit 
analysis on the raw experimental data (changes at 
394 and 418 nm as a function of pH, inset Figure 
2A), taking into account all sets of experiments 
was also performed, leading to pKa values of 8.2 ± 
0.4 and 8.1 ± 0.3 for the experiments where 
substrate displacement and binding were 
monitored, respectively. 
The pH dependence of the Kd values for 
binding were determined by titrating 0.1 to 10 µM 
androstenedione into rArom-WT purified in the 
absence of substrate. Kd values for 
androstenedione are compiled in Table 2. The Kd 
value increases three-fold from 0.4 µM to 1.2 µM 
by increasing the pH from 6.5 to 7.4. At pH 8.0, it 
was not possible to induce a complete shift of the 
Soret band from 418 to 394 nm despite the 
presence of an apparently saturating amount of 
androstenedione (10 µM). At higher pH values, no 
shift of the Soret band to 394 nm was observed. 
An increase in the Kd values is observed as the pH 
increases, showing that the binding affinity of 
rArom-WT for the substrate is higher at lower pH 
(Table 2). 
To assess the importance of reversible 
protonation of D309 for androstenedione binding, 
the pH dependence of the androstenedione-
induced spin shift was similarly investigated in the 
D309N mutant (Figure 2B).  This mutant was 
successfully expressed and purified with yields 
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comparable to those of rArom-WT in the presence 
of androstenedione. However, attempts to purify 
this mutant in the absence of ligand resulted in 
heme-free protein. This behavior precluded 
experiments titrating androstenedione into ligand-
free D309N and subsequent Kd determinations. 
Over the pH range from 6.5 to 10.0, the dithionite-
reduced D309N mutant could bind to CO yielding 
a Soret band at 450 nm in the UV-vis absorption 
spectrum, identical to that of rArom-WT. 
Conversely, the D309N mutant remained 
predominately in the high-spin state over this pH-
range (higher than 95%) (Figure 2B, 2C). The lack 
of pH dependence in substrate binding in the 
D309N mutant supports that the protonation-
deprotonation equilibrium of D309 is an important 
contributor to the pH dependence of the 
androstenedione-induced spin transition. 
 
Circular dichroism spectroscopy  
Far-UV CD spectroscopy was used to determine 
whether pH variations induce more global changes 
in rArom-WT structure that might explain the pH 
dependence of ligand binding. The CD spectra of 
ligand-free rArom-WT did not show any 
significant pH-dependent changes in the secondary 
structure of the protein (Figure 2D). Furthermore, 
the consistent molar ellipticity at 222 nm of -
17,000 deg cm2 dmol-1 corresponds to the presence 
of 50% of helical structure (22), in keeping with 
the value calculated for the crystal structure of this 
protein and with previous CD studies on other 
human cytochromes P450 (23, 24).  
 
UV-visible titrations with exemestane and 
anastrozole  
To further probe the role of the D309 protonation 
state in ligand interactions, the pH-dependence of 
rArom-WT for binding exemestane, a structural 
analog of androstenedione, and the 1,2,4-triazole 
inhibitor anastrozole were evaluated (Scheme 1B, 
1C). Crystallography supports that exemestane 
participates in a similar hydrogen-bonded 
interaction with D309 (13). By contrast, 
anastrozole that lacks a functional group to exploit 
this hydrogen bond. The latter notion is supported 
by hyperfine sub-level correlation (HYSCORE) 
spectroscopy demonstrating that a nitrogen 
nucleus from the triazole ring coordinates directly 
with the heme iron, orienting the remaining azole 
nitrogens out of reach of a D309 hydrogen bond 
(19). As expected, exemestane binding to rArom-
WT is pH-dependent (Figure 3A). Analysis of the 
pH-dependent shift from 418 nm to 394 nm using 
enzyme purified with and without exemestane 
resulted in apparent pKa values of 8.3 ± 0.1 and 
8.4 ± 0.2, respectively (Figure 3B). Similar to 
androstenedione, there is a positive correlation 
between exemestane’s Kd and pH (Table 2). The 
UV-vis spectra of the anastrozole/rArom-WT 
complexes were identical across the pH range, 
each characterized by the distinct, red-shifted 
Soret band at 422 nm (Figure 3C). Finally, the Kd 
values for anastrozole vary from 0.08 µM at pH 
8.5 to 0.29 µM at pH 7.4 with is no apparent 
correlation between pH and Kd (Table 2).  
 
Resonance Raman spectroscopy of 
androstenedione complexes. 
rR spectra were measured to investigate the 
changes in heme electronic structure resulting 
from the pH induced decrease in the high-spin 
population of rArom-WT. The high-frequency 
regions of the rR spectra of rArom-WT co-purified 
in the presence of androstenedione are illustrated 
in Figure 4A. The high frequency region of the 
spectra contains bands that are sensitive to the 
oxidation (ν4), and spin state (ν3) as well as those 
that are sensitive to the spin state and coordination 
environment (ν2).  The oxidation state vibrations, 
ν4, occur at 1374-1376 cm-1 in the spectra of 
rArom-WT at all pH values. These values are as 
expected for a P450 enzyme in the ferric oxidation 
state. Conversely, intensities of those bands that 
depend on the spin state vary substantially over 
this pH range. At pH 6.5, the predominate ν3 band 
occurs at 1488 cm-1, consistent with essentially the 
entire enzyme population in the high-spin state. As 
the pH is increased in 0.5 unit increments, the 
intensity of ν3 centered at 1488 cm-1 decreases 
while the intensity of this band increases at 1504 
cm-1 , reflecting accumulation of the low-spin state 
of the enzyme. The incremental pH increase 
likewise shifts ν2 from 1571 cm-1 to 1588 cm-1, 
also telling of the spin state shift. The high- to 
low-spin intensity ratio (R = IHS / ILS) for ν3 was 
used to calculate the relative populations of the 
high- and low- spin state at each pH value. Since 
the high-spin ν3 peak area overlaps with the 
glycerol band at 1470 cm-1, the isolated ν3 
intensity was determined by fitting the overlapping 
peaks with two Gaussian functions. The intensity 
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of the high-spin component was then determined 
by numerical integration of the peak centered at 
1488 cm-1. The corresponding ν3 band arising from 
the low spin configuration was well separated 
from the high spin component and could be fit to a 
single Gaussian function. Calculation of the 
percent of the enzyme populations in the high-spin 
configuration (HS%) were computed using the 
equation %HS = 100 • IHS / (R • ILS + IHS) .  
Nonlinear least-squares fitting (Figure 5) of the 
%HS and pH values to the equation %HS = 100 / 
1 + 1(pH-pKa) results in an apparent pKa for the high- 
to low-spin transition of 8.2 ± 0.1 (95% C. I., r2 = 
0.97).  This value corroborates the value 
determined by the UV-vis spectroscopy titration 
experiments.  
 The low frequency regions of the rR 
spectra for rArom-WT co-purified in the presence 
of androstenedione are illustrated in Figure 4B. 
The low frequency region contains the heme 
skeletal stretching modes as well as bending 
vibrations of the peripheral vinyl and propionate 
moieties. As is typical in the rR spectra of P450 
enzymes, the heme stretching modes ν7 and ν8, 
centered at 677-678 and 345 cm-1 are resistant to 
pH titration in the presence of androstenedione. In 
rArom-WT, the dominant propionate bending 
frequency (δprop) appears at 378 cm-1 and the 
peripheral vinyl bending modes (δvinyl) appears at 
417 cm-1. Fitting of the δvinyl envelopes generally 
resulted in two components centered at 413-415 
cm-1 and 422-427 cm-1, with the blue-shifted 
extremes dominating at higher pH values. These 
assignments are made based on the complete 
vibrational assignments of the heme in myoglobin 
and cytochrome c (25, 26). Changes in the 
chemical environments surrounding these 
functional groups are reflected in shifts of the 
corresponding frequencies in the rR spectrum. The 
δpropionates frequency positions provide insight into 
the hydrogen bonding and/or ionic interactions 
surrounding the heme propionates that anchor the 
cofactor into the active site. The low-frequency 
region of the rR spectra of rArom-WT at different 
pH are nearly identical, supporting that pH 
titration does not influence the enzyme 
environment surrounding the heme periphery or 
change the hydrogen-bonding and/or ionic 
interactions anchoring the propionates into the 
aromatase active site. These spectra confirm that 
pH does not influence the immediate environment 
of the heme macrocycle.    
  As in the UV-vis experiments, rR spectra 
of the D309N mutant were likewise collected in 
the presence of 10 µM androstenedione (Figure 
4C, 4D). The D309N mutation conservatively 
replaces the D309 side chain with a nontitratable 
functional group capable of contributing a 
hydrogen bond to the 3-keto O atom over the 
entire pH range evaluated. Indeed, rR spectra in 
the high frequency region are identical from pH 
6.5 to 9.0 and the enzyme populations are 
essentially entirely high-spin (Figure 4C). 
Calculation of the percentage of enzyme in the 
high-spin state using the previously described 
Gaussian line shape analysis confirmed that the 
D309N mutant remained greater than 90% high 
spin over the pH range (Figure 5). Furthermore, 
features of the low frequency region, most notably 
the δprop and δvinyl are likewise similar to that 
observed for rArom-WT (Figure 4D). The 
constitutive protonation of the asparagine side 
chain putatively maintains the binding of 
androstenedione over the functional pH range and 
the identical positions and pH resistance of the 
vibrational markers reporting the heme 
environment support that the neither the mutation 
or pH perturb the heme-androstenedione 
interaction.   
 
Resonance Raman spectroscopy of exemestane 
and anastrozole complexes  
The rR spectra of rArom-WT in the presence of 10 
µM exemestane and 20 µM anastrozole were 
measured to monitor the pH dependent changes in 
heme electronic structure and environment in the 
presence of these ligands. rR spectra of rArom-
WT with exemestane mirror those with 
androstendione. In the high frequency region, both 
ν3 and ν2 shift from their high-to low-spin 
positions in a pH-dependent manner (Figure 6A). 
Lineshape analyses of the ν3 bands results in an 
apparent pKa of 8.4 ± 0.1 (95% C. I., r2 = 0.94) 
(Figure 5). This value is also in close agreement 
with the values determined in UV-vis experiments. 
The rR spectra of the low-frequency region also 
mirror those of the androstendione complex and 
display the same features across the pH range, 
illustrating that pH does affect the immediate 
heme environment in the exemestane complex. 
Spectra of the rArom-WT-anastrozole complexes 
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are nearly superimposable; though in contrast to 
androstenedione they reveal that aromatase 
remains entirely in the low-spin state, with ν3 and 
ν2 bands occurring at 1504 cm-1 and 1588 cm-1, 
respectively (Figure 6C). Likewise, the positions 
of ν8, δprop, and δvinyl also remain fixed, indicating 
that pH also apparently does not affect the 
environments of the heme peripheral substituents 
in the anastrozole-rArom-WT complex (Figure 
6D). 
 
rArom-WT enzyme kinetics. Aromatase activity as 
function of pH was previously studied using a 
microsomal system and reported to be pH 
dependent with an optimum at pH 7.4 (27). 
Following establishment of the elevated pKa for 
D309, we assessed the role of pH in regulating 
aromatase catalytic parameters in the 
physiological pH 6.5-7.4. Androstenedione is 
capable of saturating the enzyme and consistently 
induces a high spin transition of the enzyme in this 
pH range. Intracellular pH can vary by ±0.9 pH 
units, as in neuronal firing. The catalytic activity 
of rArom-WT purified in the ligand-free form was 
assayed at pH 6.5, 7.0 and 7.4 by measuring 
rArom-WT-catalyzed release of 3H2O from 1β-3H-
androstenedione. At these pH values, the reaction 
rate increased hyperbolically with increasing 
substrate concentration. The experimental data 
were fitted to the Michaelis-Menten equation to 
obtain the values of KM and Vmax reported in Table 
3. The KM values increase ~1.5-fold from pH 6.5 
to 7.4 and there is a positive correlation between 
these values and the Kd values determined in UV-
vis titration experiments.  
 
DISCUSSION 
Ionizable residues in proteins are of profound 
importance for enzyme catalysis, structural 
stability and protein-ligand interactions. The pKa 
values of ionizable residues depend strongly on 
their electrostatic environment. Thus, their degree 
of solvation by water and ions as well as the nature 
of neighboring residues, especially their charge 
states, influence these values. Forsyth and 
coworkers surveyed 200 protein carboxyl amino 
acid pKa values determined by NMR and 
identified empirical relationships between 
descriptors of the aspartate or glutamate milieu 
and their pKa values (28). Relevant environmental 
factors included the solvent accessible surface 
area, electrostatic potential and the number of 
hydrogen bonds involved.  The mean pKa value of 
aspartates among these proteins was 3.4 ± 1.0 
units. Aspartate residues having pKa values greater 
than 5.5 were predominately buried in enzyme 
active sites with solvent accessible surface areas of 
less than 20 Å2. These residues’ environments 
were characterized by a low electrostatic potential 
and few if any hydrogen bonds (28). 
Many cytochrome P450 enzymes carry 
adjacent, conserved amino acids in their active 
sites known as the “acid-alcohol” pair. The D251-
T252 pair in CYP101 has undergone extensive 
mutagenesis and biophysical studies to support 
that these residues are critical to delivering protons 
to reduced oxygen intermediates and drive the 
canonical P450 catalytic cycle (29-31). The proton 
delivery mechanism that has been generally 
accepted for P450s requires that the acidic residue 
is first protonated, and this proton is relayed to the 
ferric peroxo and ferric hydroperoxo intermediates 
in the catalytic cycle via the hydroxyl oxygen of 
the alcohol residue. Insomuch that a corresponding 
acid-alcohol pair is conserved in aromatase, it is 
reasonable that an analogous proton delivery 
mechanism is operative. However, in crystal 
structures with androstenedione and inhibitors 
based on this scaffold, these ligands intervene in 
the proton delivery network through an apparent 
hydrogen bond to D309. Additionally, the 13 Å2 
solvent accessible surface area of this residue is in 
line with other protein aspartates known to have 
elevated pKa values. Both of these features are 
consistent with D309 protonation at physiological 
pH. In accord with these observations, 
computational prediction using PROPKA3, an 
approach that carefully accounts for desolvation 
and electrostatic contributions, estimates the D309 
pKa to range from 7.7-8.1 among the available 
crystal structures. These estimates are 4.3-4.7 units 
higher than the average pKa values reviewed by 
Forsyth and coworkers. In view of the inferred 
importance of D309 in proton delivery, ancillary 
observations in crystallography and strong 
computational support for protonation of this 
residue, a complementary experimental approach 
was used to investigate the pKa value of this 
residue as a validation of the theoretical 
predictions.    
 In many proteins, the direct measurement 
of the pKas of multiple ionizable side chains can 
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be simultaneously measured using NMR. Such 
measurements in the active site of P450 enzymes 
are complicated by the presence of the 
paramagnetic ferric ion. Attempts to silence this 
effect, such as generation of the diamagnetic 
carbonmonoxy-ferrous complex, often fail because 
these species are not stable for the time required at 
ambient temperature required to collect the 
chemical shift data. In this work, site-directed 
mutagenesis, UV-vis absorption, rR spectroscopy 
and enzyme kinetics were used to probe the role of 
D309 in maintaining androstenedione in a binding 
orientation that induces the high- to low-spin 
transition of the heme iron. Collectively, these 
approaches indeed measure a clear effect of D309 
protonation on ligand binding and enzymatic 
activity, and hence provide an indirect 
measurement of the pKa. The integrated approach 
affords exclusion of structural perturbations, other 
than the protonation/deprotonation of D309, as 
predominant contributors to the observed pH 
dependence of androstenedione binding to 
aromatase.   
 These results demonstrate that the binding 
of androstenedione is pH dependent and the 
apparent pKa for the spin transition is ~8.2. The 
KM for androstenedione was shown to increase 
going up to pH 7.4 and there is a positive 
correlation between the KM and the Kd values 
determined spectrophotometrically. Similar trends 
are observed for exemestane; however the 
predicted pKa is slightly higher than that obtained 
with androstenedione. This observation is likely 
attributable to additional hydrophobic contacts 
between exemestane and the active site that 
contribute to its higher binding affinity. 
Conversely, the D309N mutant binds to 
androstenedione and remains greater than 90% 
high spin over the investigated pH range. The 
results support that while a protonated residue in 
the 309 position is requisite for positioning 
androstenedione in the active site, reversible 
protonation is necessary for catalytic activity. The 
observations are both consistent with the putative 
proton delivery function of this residue and the 
recently proposed mechanism for the 
deformylation reaction (10) Both the low-
frequency region of the rR spectra and circular 
dichroism studies narrow the pH-dependence to 
the protonation state of D309. The environments 
of the heme vinyl groups and the hydrogen 
bonding environments of the propionates are 
independent of pH in both rArom-WT and the 
D309N mutant. Furthermore, circular dichroism 
studies do not reveal substantial changes in the 
secondary structure of the enzyme while varying 
the pH. Anastrozole, a triazole inhibitor of 
aromatase that does not require interaction with 
D309 binds to aromatase in a pH independent 
manner. Both the measured Kd values and low 
frequency rR spectra are the same across the pH 
range. The strong evidence supporting the 
necessity for reversible protonation of D309 for 
substrate binding and catalysis and the evidence 
opposing that the observed pH dependence does 
not result from global structural perturbations of 
the enzyme, led us to assign a pKa of 8.2 to D309 
in the active site of aromatase. 
In addition to affording aromatase 
mechanistic flexibility, the elevated pKa of this 
residue may have physiological significance as 
well. Aromatase is expressed in extragonadal 
tissues, including the brain where intracellular pH 
changes are detected for example in both neurons 
and glial cells in response to electrical stimulation 
or membrane ligands (32-38). Kinetic parameters 
were evaluated over the pH range in which 
androstenedione demonstrated induction of the 
low- to high-spin transition (6.5-7.4). This pH 
range is chosen also on the basis of previous 
reports showing that in vertebrate neurons 
different depolarizing stimuli such as application 
of excitatory amino acids and glutamate also 
induce pH acidification followed by alkalinization, 
altering the pH by 0.9 pH units (37, 38).  
In conclusion, we have applied an 
integrated approach to investigate the possibility 
of and extraordinarily elevated pKa for D309 of 
the conserved acid-alcohol pair in the active site of 
human aromatase. Taken together with previous 
investigation, these results support that protonation 
of this residue is necessary for androstenedione 
binding, while reversible protonation is necessary 
for catalytic turnover. The agreement between the 
empirical pKa prediction based on the rArom-WT 
crystal structure (PDB ID: 4KQ8) and the 
experimental measurements is remarkable despite 
the approximations made in the computational 
approach, including ignorance of protein 
dynamics. This study underscores the value of 
such methods to support interpretation of 
experimental results. While the importance of 
11 
D309 protonation has been illustrated in molecular 
dynamics and QM/MM studies, the physiological 
impact of such fine regulation remains unclear. 
This phenomenon may be relevant in the brain 
where rapid changes in estrogen levels might be 
correlated with small alterations of pH during 
neurotransmission. To our knowledge, this work 
represents the first experimental assignment of a 
pKa value in the active site of a cytochrome P450 
enzyme. 
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Figure and Scheme Legends. 
 
Scheme 1. A) Summary of aromatase reaction with the conversion of androstenedione to estrone via 19-
oxoandrostenedione. The reversible protonation of D309 is illustrated for the final step. B) The chemical 
structure of anastrozole. C) The chemical structure of exemestane. 
 
Figure 1. Active site of human aromatase (PDB ID 4KQ8). The 3-keto oxygen atom of androstenedione 
(blue) is within hydrogen-bonding distance (2.9 Å) of the D309 side chain.  
 
Figure 2. A) UV-vis spectra of rArom-WT in complex with 10 µM androstenedione at pH 6.5 (solid 
black line), 7.0 (dashed grey line), 7.4 (dotted black line) 8.0 (solid dark grey line), 8.5 (dashed black 
line) and 10.0 (light grey solid line); Inset: plot of the absorbance values at 394 nm (white squares) and 
418 nm (black squares) as a function of pH. B) UV-vis spectra of rArom-D309N in complex with 10 µM 
androstenedione at pH 6.5 (solid black line), 7 (solid grey line) and 9.0 (dashed black line). Spectra were 
collected using 1 µM of rArom in a 0.1 cm path length cell. C) Titration curves resulting from spectral 
transitions with varying pH observed for rArom-WT purified in the absence of ligand incubated with 10 
µM of androstenedione (white squares fitted by the dashed line), for rArom-WT co-purified with 10 µM 
of androstenedione (black circles fitted by the solid line) and rArom-D309N co-purified with 500 µM 
androstenedione (black triangles); D) Far-UV CD spectra of rArom-WT at pH 6.5 (solid black line), 7 
(solid grey line) and 10 (dashed black line). 
 
Figure 3. A) UV-vis spectra of rArom-WT in complex with 10 µM exemestane at pH 6.5 (solid black 
line), 8.0 (dotted black line) 8.5 (solid grey line) and 9.0 (dashed black line). Spectra were collected using 
1.2 µM of rArom in a 0.1 cm path length cell.  B) Titration curves resulting from spectral transitions with 
varying pH observed for rArom-WT purified in the absence of ligand incubated with 10 µM of 
exemestane (black circles fitted by the solid line) and for rArom-WT co-purified with 10 µM of 
exemestane (white squares fitted by the dashed line). C) UV-vis spectra of rArom-WT (1.5 µM) in 
complex with 1 µM anastrozole at pH 6.5 (solid black line), 8.0 (dotted black line) 8.5 (solid grey line) 
and 9.0 (dashed black line).  
 
Figure 4. rR spectra of rArom-WT-androstenedione and rArom-D309N-androstenedione complexes at 
pH 6.5-9.0 with 406.7 nm laser excitation. The high-frequency (A) and low-frequency (B) regions of the 
rR spectra of rArom-WT and the high-frequency (C) and low-frequency (D) regions of the rArom-D309N 
mutant in the presence of 10 µM androstenedione are illustrated. Spectra in the high- and low-frequency 
regions were normalized to ν4 and ν7, respectively. Proteins were purified in the presence of 
androstenedione as described in the Experimental Procedures. Protein concentrations were 10-15 µM.  
 
Figure 5. pH-dependence of the high-spin content of rArom-WT-androstenedione (solid circles), rArom-
WT-exemestane (open squares), and rArom-D309N (open circles). Intensities for the high- and- low spin 
positions of ν3 were determined by numerical integration of their corresponding Gaussian line shapes. 
Error bars are ± standard deviation.  
 
Figure 6. rR spectra of rArom-WT-exemestane and rArom-WT-anastrozole complexes at pH 6.5-9.0 with 
406.7 nm laser excitation. The high-frequency (A) and low-frequency (B) regions of the rR spectra of 
rArom-WT in the presence of 10 µM exemestane and the high-frequency (C) and low-frequency (D) 
regions of the rArom-WT in the presence of 20 µM anastrozole are illustrated. Spectra in the high- and 
low-frequency regions were normalized to ν4 and ν7, respectively. Proteins were purified in the presence 
15 
of exemestane and anastrozole as described in the Experimental Procedures. Protein concentrations were 
10-15 µM.  
Table 1. Predicted pKa values of D309 in available aromatase crystal structures.  
 
PDB Entry Ligand D309 pKa Reference 
3EQM Androstenedione 7.7 (10) 
3S7S Exemestane 7.9 (13) 
3S79 Androstenedione 7.7 (13) 
4GL5 (6 α,8α)-6-(But-2-yn-1-yloxy)-androstenedione 7.8 (13) 
4GL7 (6α,8α)-6-(Pent-2-yn-1-yloxy)-androstenedione 7.7 (13) 
4KQ8 Androstenedione 8.1 (12) 
 
 
 
Table 2. Dissociation constants (Kd) of rArom-WT for the substrate androstenedione and the inhibitor 
anastrozole obtained at different pH.  
 
pH Kd androstenedione (µM) Kd exemestane (µM) Kd anastrozole (µM) 
6.5 0.4±0.1 0.25±0.13 0.13±0.03 
7.0 0.9±0.1 0.42±0.17 0.19±0.03 
7.4 1.2±0.1 0.61±0.04 0.29±0.03 
8.0 2.6±0.2 2.8±0.2 0.23±0.02 
8.5 No spin shift No spin shift 0.08±0.01 
9.0 No spin shift No spin shift 0.13±0.02 
 
 
 
 
Table 3. Catalytic parameters (KM and Vmax) of rArom-WT for the substrate androstenedione obtained at 
three different pH values. 
 
pH KM (nM) Vmax (nmol product/min/mg protein) 
6.5 221±20 17.8±0.8 
7.0 266±25 23.5±1.1 
7.4 334±42 19.8±3.0 
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Figure 5 
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Figure 6 
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